Summary

Eligibility
for people ages 11-17 (full criteria)
Healthy Volunteers
healthy people welcome
Dates
study started
completion around

Description

Summary

This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.

Official Title

A Feasibility and Efficacy Study of NeuroTrainer Cognitive Training in Students With and Without Attention-Related Difficulties

Details

The goal of this clinical trial is to test the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control function in students with and without attention-related difficulties. The main questions it aims to answer are (1) does NeuroTrainer improve attentional and executive control function, (2) does NeuroTrainer engage the target of ADHD inattention symptoms by identifying the target and demonstrating proximal changes in it, and (3) does NeuroTrainer demonstrate transfer of skill with improvement in academic behaviors. Researchers will compare students who use NeuroTrainer to a control condition to see if the NeuroTrainer intervention produces significant improvements.

Participants in the intervention group will engage in virtual reality (VR) sessions which include physical activity and cognitive training. Cognitive training will maximize time at performance thresholds and optimize for variability in task dynamics and demands.

Keywords

ADHD - Combined Type, ADHD Predominantly Inattentive Type, ADHD, Predominantly Hyperactive - Impulsive, Hyperkinesis, NeuroTrainer

Eligibility

You can join if…

Open to people ages 11-17

  • Diagnostic criteria met ADHD for any ADHD presentation type, with severity ratings of subthreshold, moderate or severe
  • Estimated IQ of 80 or greater
  • Between 11-17 years of age

You CAN'T join if...

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
NeuroTrainer
ID
NCT06512974
Study Type
Interventional
Participants
Expecting 155 study participants
Last Updated